We are the authorized channel partners of Glen Research and Trilink BioTechnologies. BioServe will distribute the products and services of Glen Research and TriLink BioTechnologies in India, Sri Lanka, Bangladesh and Nepal. Glen Research and TriLink BioTechnologies, a subsidiary of Maravai Lifesciences, are known worldwide for synthesizing high-quality nucleic acid products for medical, diagnostic, and therapeutic applications. These products are used by academic and biopharmaceutical clients working in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and next-generation sequencing.
Glen Research is a leading provider of reagents for synthesis, labelling, and modification of DNA and RNA oligonucleotides.
TriLink also provides state-of-the-art CRISPR / Cas9 and mRNA synthesis, capping and transcription reagents. This distribution agreement will enable BioServe India to offer the services of a leading contract manufacturing organisation for GMP mRNA development to Indian researchers and biopharmaceutical companies.